Maprotiline Hydrochloride

CAS 10347-81-6 1 current record 2 historicalSmall Molecule

Who holds supplier records for Maprotiline Hydrochloride? 1 organisation holds a current record for Maprotiline Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Maprotiline Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/maprotiline-hydrochloride

Reading the evidence

  • One current record

    One organisation holds a current DMF or CEP. A record shows a regulatory filing, not current commercial availability or a qualified source for your product.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (1)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Maprotiline Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • OLON SPA
    Active DMF 7096 · latest filing Aug 1987
    ItalyCEP Company GMP cert on record
Need Maprotiline Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Maprotiline Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
OLON S.P.A. RodanoIT
CEP 2006-290 - Rev 09
Maprotiline hydrochloride
Mar 2025Inspected Mar 2025
Italy

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Maprotiline Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
    Inactive DMF 7018 · filed Jun 1987
  • BALENCO ENTERPRISES INC
    Inactive DMF 6730 · filed Dec 1986

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Maprotiline Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1237135).

Chemical identity

IUPAC name
N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;hydrochloride
Canonical SMILES
CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24.Cl
InChIKey
NZDMFGKECODQRY-UHFFFAOYSA-N
Synonyms
BA-34,276, BA-34276, BA-34276 HYDROCHLORIDE, Ludiomil, Maprotiline hcl, Maprotiline hydrochloride, NSC-757085, RefChem:57782, Hydrochloride, Maprotiline, Ba34,276, Psymion, Maprotiline Hydrochlorine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Maprotiline Hydrochloride?

1 organisation holds an active US FDA Type II Drug Master File or a CEP for Maprotiline Hydrochloride: OLON SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Maprotiline Hydrochloride Drug Master Files are active?

OLON SPA (DMF 7096). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Maprotiline Hydrochloride records mean?

2 organisations have only inactive Type II DMFs for Maprotiline Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Maprotiline Hydrochloride have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Maprotiline Hydrochloride on the EDQM register, including OLON S.P.A. Rodano (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Maprotiline Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Maprotiline Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.